Neurodegeneration blood markers in largely Hispanic and non‐Hispanic Black COVID‐19 patients: from acute hospitalization to long‐term PASC with/without brain fog

Understanding the effect of COVID‐19 and Post‐Acute Sequelae of SARS CoV‐2 infection (PASC) on neurodegeneration using accessible blood biomarkers of neurofilament light (NfL) and phosphorylated tau 181 (p‐tau‐181) is of critical importance. Few studies to date have explored levels of neurodegenerative markers in COVID‐19 and PASC among race and ethnic minority populations.